$IBB Company News Nasdaq action keeps speculat
Post# of 74540
Nasdaq action keeps speculators on hold 2:27 p.m. Jan. 30, 2015 - The Trading Deck
Major U.S. benchmarks challenge last-ditch support 11:31 a.m. Jan. 20, 2015 - Michael Ashbaugh
Major U.S. benchmarks challenge last-ditch support 11:09 a.m. Jan. 20, 2015 - Michael Ashbaugh
Updates, advisories and surprises 12:31 p.m. Jan. 12, 2015 - MarketWatch
Celgene's stock rises, but off highs after profit outlook 11:49 a.m. Jan. 12, 2015 - Tomi Kilgore
More records for U.S. stocks as Dow tops 18,000 for first time 4:05 p.m. Dec. 23, 2014 - Anora Mahmudova
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 spikes from major support 11:32 a.m. Dec. 11, 2014 - Michael Ashbaugh
Charting the latest slow-motion breakout attempt 11:22 a.m. Dec. 4, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:51 a.m. Nov. 25, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:29 a.m. Nov. 25, 2014 - Michael Ashbaugh
The trouble with fundamentals 1:38 p.m. Nov. 11, 2014 - The Trading Deck
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Barron’s Roundtable: Strategies for a New Age 2:46 p.m. Feb. 2, 2015 - Barrons.com
Some Pre-Earnings Release Observations About Gilead Sciences 11:02 a.m. Feb. 2, 2015 - Seeking Alpha
Is the 'January Effect' Signaling a Down Year for the Stock Market? 3:14 p.m. Jan. 30, 2015 - TheStreet.com
A Time To Cheer Or A Time To Cry 11:22 a.m. Jan. 30, 2015 - Seeking Alpha
IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks? 10:07 a.m. Jan. 30, 2015 - Seeking Alpha
IShares Nasdaq Biotechnology ETF Experiences Big Outflow 10:53 a.m. Jan. 28, 2015 - TheStreet.com
Will You Miss The Netflix Ride To $1,000? 11:16 a.m. Jan. 27, 2015 - Seeking Alpha
Tech ETF IBB Brings Plenty Of Risk But It Fits Nicely In A Portfolio 10:14 a.m. Jan. 27, 2015 - Seeking Alpha
A New Biotech ETF Looks To Bring The Genomic Revolution To Investors 1:28 p.m. Jan. 23, 2015 - Seeking Alpha
Play the Biotech Boom With IBB 8:16 a.m. Jan. 21, 2015 - InvestorPlace.com
These 2 Charts Should Give Any Investor Pause 8:35 p.m. Jan. 20, 2015 - InvestorPlace.com
Will Mario Draghi Put A Floor Under Oil? 3:33 a.m. Jan. 19, 2015 - Seeking Alpha
Gilead: A Bullish Update 2:08 p.m. Jan. 16, 2015 - Seeking Alpha
A New Biotech ETF Targets Companies In Late Stage Clinical Trials 11:45 a.m. Jan. 16, 2015 - Seeking Alpha
ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF 12:48 a.m. Jan. 15, 2015 - Seeking Alpha
ALPS Puts Twist on Biotech Investing with Medical Breakthrough ETF - ETF News And Commentary 8:04 a.m. Jan. 14, 2015 - Zacks.com
Sidelines are Safest Until the Whipsaws End 8:19 p.m. Jan. 11, 2015 - InvestorPlace.com
'Fast Money' Recap: DJIA Cleans the Slate, Erases 2015 Losses 5:00 a.m. Jan. 9, 2015 - TheStreet.com
Kyle Bass's Assault On Pharma Patents 1:25 p.m. Jan. 8, 2015 - Seeking Alpha
FOMC, Oil Rebound Shake the Bulls Awake 11:30 a.m. Jan. 7, 2015 - InvestorPlace.com
Biotechs to Follow in 2015 off Fresh Insider Moves 10:01 a.m. Jan. 6, 2015 - ACCESSWIRE
GW Pharmaceuticals Added to NASDAQ Biotechnology Index 2:00 a.m. Dec. 22, 2014 - GlobeNewswire
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Revance Therapeutics Added to NASDAQ Biotechnology Index 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Cara Therapeutics Announces Addition to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 18, 2014 - GlobeNewswire
Relypsa to be Added to NASDAQ Biotechnology Index 8:01 a.m. Dec. 17, 2014 - GlobeNewswire
Alder BioPharmaceuticals Announces Addition to NASDAQ Biotechnology Index 4:02 p.m. Dec. 16, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Zafgen Added to NASDAQ Biotechnology Index 7:01 a.m. Dec. 16, 2014 - GlobeNewswire
Foundation Medicine to Be Added to NASDAQ Biotechnology Index 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Added to NASDAQ Biotechnology Index (NBI) 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire